Combination Azacitidine and Lenalidomide: A Novel Relapse Prophylaxis Option in Patients after Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Yimei Feng(Xinqiao Hospital), Xi Zhang(Army Medical University), Ting Chen(Nanchang University), Lu Zhao(Liaoning Provincial People's Hospital), Yuqing Liu(Central South University), Han Yao(Army Medical University), Lei Gao(Zhejiang Chinese Medical University), Yun Zhang(Kunming Institute of Zoology), Peiyan Kong(Army Medical University), Lu Wang(Beijing Tsinghua Chang Gung Hospital)
Cited by 0
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
Strategies to enhance CAR-T persistence
|Biomarker Research|2022|90
Characteristics of acute myeloid leukemia with myelodysplasia‐related changes: A retrospective analysis in a cohort of <scp>Chinese</scp> patients
|American Journal of Hematology|2014|56